Raffles Medical Group Ltd disclosed on Apr, 1 2026 that Dr Lu Liangjian David will join the Audit & Risk Committee as a member with effect from Apr, 25 2026.

The company added that Non-Executive directors Mr Tan Soo Nan and Mr Lim Sim Seng will retire after the Annual General Meeting scheduled for Apr, 24 2026.

From Apr, 25 2026, the board will comprise Executive Chairman Dr Loo Choon Yong; Lead Independent Director Mr Lew Yoong Keong Allen; Non-Executive and Independent Directors Mr Png Cheong Boon, Mr Tan Wern Yuen, Ms Chong Chuan Neo and Professor Sung Jao Yiu; Non-Executive and Non-Independent Director Mr Olivier Lim Tse Ghow; Executive and Non-Independent Director Dr Sarah Lu Qinghui; and Non-Executive and Non-Independent Director Dr Lu Liangjian David.

The reconstituted Audit & Risk Committee will be chaired by Mr Lew Yoong Keong Allen with Mr Tan Wern Yuen and Dr Lu Liangjian David as members. The Nomination & Compensation Committee will be chaired by Mr Png Cheong Boon, with Mr Lew Yoong Keong Allen, Ms Chong Chuan Neo and Professor Sung Jao Yiu as members.